BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3878055)

  • 1. Plasma fibronectin, von Willebrand factor antigen, and blood rheology. Association with diabetic microvascular disease.
    Solerte SB; Piovella F; Viola C; Schianca GC; Gamba G; Fioravanti M; Ferrari E
    Acta Diabetol Lat; 1985; 22(3):239-46. PubMed ID: 3878055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Von Willebrand factor (VIII R:Ag), fibronectin, and insulin-like growth factors I and II in diabetic retinopathy and nephropathy.
    Lamberton RP; Goodman AD; Kassoff A; Rubin CL; Treble DH; Saba TM; Merimee TJ; Dodds WJ
    Diabetes; 1984 Feb; 33(2):125-9. PubMed ID: 6363166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemorheology, plasma protein composition and von Willebrand factor in type I diabetic nephropathy.
    Zimmermann J; Schramm L; Wanner C; Mulzer E; Henrich HA; Langer R; Heidbreder E
    Clin Nephrol; 1996 Oct; 46(4):230-6. PubMed ID: 8905207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated levels of plasma von Willebrand factor and the risk of macro- and microvascular disease in type 2 diabetic patients with microalbuminuria.
    Gaede P; Vedel P; Parving HH; Pedersen O
    Nephrol Dial Transplant; 2001 Oct; 16(10):2028-33. PubMed ID: 11572892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic alterations in long-term insulin-dependent diabetic patients with overt nephropathy: role of blood hyperviscosity and plasma protein changes.
    Solerte SB; Fioravanti M
    Clin Nephrol; 1987 Sep; 28(3):138-43. PubMed ID: 3665207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma type IV collagen and fibronectin concentrations in diabetic patients with microangiopathy.
    Lee IK; Park KY; Oh HK; Park RW; Jo JS
    J Korean Med Sci; 1994 Aug; 9(4):341-6. PubMed ID: 7848583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma fibronectin, factor VIII-related antigen and fibrinogen concentrations, and diabetic retinopathy.
    Davis TM; Moore JC; Turner RC
    Diabete Metab; 1985 Jun; 11(3):147-51. PubMed ID: 3928410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Modification of hemorheological parameters in microvascular complications of diabetes].
    Bauduceau B; Renaudeau C; Mayaudon H; Hélie C; Ducorps M; Sonnet E; Yvert JP
    Diabete Metab; 1995 Jun; 21(3):188-93. PubMed ID: 7556810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. von Willebrand factor and early diabetic retinopathy: no evidence for a relationship in patients with type 1 (insulin-dependent) diabetes mellitus and normal urinary albumin excretion.
    Stehouwer CD; Zellenrath P; Polak BC; Baarsma GS; Nauta JJ; Donker AJ; den Ottolander GJ
    Diabetologia; 1992 Jun; 35(6):555-9. PubMed ID: 1612229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macro-microangiopathy and endothelial dysfunction in NIDDM patients with and without diabetic nephropathy.
    Parving HH; Nielsen FS; Bang LE; Smidt UM; Svendsen TL; Chen JW; Gall MA; Rossing P
    Diabetologia; 1996 Dec; 39(12):1590-7. PubMed ID: 8960847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrinsic stiffening of red blood cells as the fundamental cause of diabetic nephropathy and microangiopathy: a new hypothesis.
    Simpson LO
    Nephron; 1985; 39(4):344-51. PubMed ID: 3885063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?
    Chico A; Pérez A; Córdoba A; Arcelús R; Carreras G; de Leiva A; González-Sastre F; Blanco-Vaca F
    Diabetologia; 1998 Jun; 41(6):684-93. PubMed ID: 9662051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rheological changes in diabetic microangiopathy.
    Negrean V; Suciu I; Sâmpelean D; Cozma A
    Rom J Intern Med; 2004; 42(2):407-13. PubMed ID: 15529630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum and urinary concentrations of type IV collagen and laminin as a marker of microangiopathy in diabetes.
    Hayashi Y; Makino H; Ota Z
    Diabet Med; 1992 May; 9(4):366-70. PubMed ID: 1600709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma free N-terminal fibronectin 30-kDa domain as a marker of endothelial dysfunction in type 1 diabetes mellitus.
    Skrha J; Vacková I; Kvasnicka J; Stibor V; Stolba P; Richter H; Hörmann H
    Eur J Clin Invest; 1990 Apr; 20(2):171-6. PubMed ID: 2112482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal endothelial release of fibrinolytic activity and fibronectin in diabetic microangiopathy.
    Haitas B; Barnes AJ; Cederholm-Williams SA; Moore J; Shogry ME; Turner RC
    Diabetologia; 1984 Nov; 27(5):493-6. PubMed ID: 6510595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma fibronectin as an indicator of microvascular damage in diabetic patients. Rapid and sensitive evaluation by a radial immunodiffusion technique.
    Solerte SB; Fioravanti M; Ferrari E
    Ric Clin Lab; 1987; 17(3):251-8. PubMed ID: 3118445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. von Willebrand factor antigen in plasma and urine in patients with type I (insulin-dependent) diabetes mellitus with and without nephropathy.
    Silveira AM; Sjöberg S; Blombäck M; Ostman J
    J Diabetes Complications; 1992; 6(2):89-95. PubMed ID: 1611144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood hyperviscosity and its relationship to progressive renal failure in patients with diabetic nephropathy.
    Gordge MP; Patel A; Faint RW; Rylance PB; Neild GH
    Diabet Med; 1990 Dec; 7(10):880-6. PubMed ID: 2149685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemorheologic and coagulation study in a group of patients with diabetic retinopathy].
    Parenti M; Pasquali R; Sorrenti G; Babini AC; Melchionda N; Palareti G; Poggi M; Tricarico G
    G Clin Med; 1984; 65(9-10):409-18. PubMed ID: 6442246
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.